Industry Research Reports

Home > Reports > Service & Software > Global Nanobody Sequence Library Market Research Report 2025

Global Nanobody Sequence Library Market Research Report 2025

Industry: Service & Software

Published Date: 2025-03-11

Pages: 82 Pages

Report ld: 4636904

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Nanobody Sequence Library was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Nanobody (Nb) is an artificially designed antibody molecule, also known as single-domain antibodies (sdAbs), VHH antibodies or camelid antibodies. It is a kind of heavy-chain antibodies (HCAbs) that naturally lack light chains and are found in camelids such as alpacas and dromedaries, as well as cartilaginous fish such as sharks and rays. There are monovalent nanobodies, bivalent nanobodies, bispecific nanobodies, multivalent nanobodies and fused nanobodies.

North American market for Nanobody Sequence Library is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Nanobody Sequence Library is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Nanobody Sequence Library in Drug Development is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Nanobody Sequence Library include GenScript ProBio, Abiocenter, Abace Biotechnology, KMDTM Bioscience, Sino Biologics, WuXi Biologics, Creative Biolabs, Twist Bioscience, ProteoGenix, Fortis Life Sciences, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Nanobody Sequence Library, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nanobody Sequence Library.

The Nanobody Sequence Library market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nanobody Sequence Library market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Nanobody Sequence Library companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

MARKET SEGMENTATION

By Company

GenScript ProBio
Abiocenter
Abace Biotechnology
KMDTM Bioscience
Sino Biologics
WuXi Biologics
Creative Biolabs
Twist Bioscience
ProteoGenix
Fortis Life Sciences
Synbio Technologies
KMD Bioscience

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Immune Library
Natural Library
Fully Synthetic Library

Segment by Application

Drug Development
Vaccine Research
Biosensors
Tumor Treatment
Diagnostic Tools

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Nanobody Sequence Library company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Nanobody Sequence Library Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Immune Library

1.2.3 Natural Library

1.2.4 Fully Synthetic Library

1.3 Market by Application

1.3.1 Global Nanobody Sequence Library Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Drug Development

1.3.3 Vaccine Research

1.3.4 Biosensors

1.3.5 Tumor Treatment

1.3.6 Diagnostic Tools

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Nanobody Sequence Library Market Perspective (2020-2031)

2.2 Global Nanobody Sequence Library Growth Trends by Region

2.2.1 Global Nanobody Sequence Library Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Nanobody Sequence Library Historic Market Size by Region (2020-2025)

2.2.3 Nanobody Sequence Library Forecasted Market Size by Region (2026-2031)

2.3 Nanobody Sequence Library Market Dynamics

2.3.1 Nanobody Sequence Library Industry Trends

2.3.2 Nanobody Sequence Library Market Drivers

2.3.3 Nanobody Sequence Library Market Challenges

2.3.4 Nanobody Sequence Library Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Nanobody Sequence Library Players by Revenue

3.1.1 Global Top Nanobody Sequence Library Players by Revenue (2020-2025)

3.1.2 Global Nanobody Sequence Library Revenue Market Share by Players (2020-2025)

3.2 Global Nanobody Sequence Library Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Nanobody Sequence Library Revenue

3.4 Global Nanobody Sequence Library Market Concentration Ratio

3.4.1 Global Nanobody Sequence Library Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Nanobody Sequence Library Revenue in 2024

3.5 Global Key Players of Nanobody Sequence Library Head office and Area Served

3.6 Global Key Players of Nanobody Sequence Library, Product and Application

3.7 Global Key Players of Nanobody Sequence Library, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Nanobody Sequence Library Breakdown Data by Type

4.1 Global Nanobody Sequence Library Historic Market Size by Type (2020-2025)

4.2 Global Nanobody Sequence Library Forecasted Market Size by Type (2026-2031)

5 Nanobody Sequence Library Breakdown Data by Application

5.1 Global Nanobody Sequence Library Historic Market Size by Application (2020-2025)

5.2 Global Nanobody Sequence Library Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Nanobody Sequence Library Market Size (2020-2031)

6.2 North America Nanobody Sequence Library Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Nanobody Sequence Library Market Size by Country (2020-2025)

6.4 North America Nanobody Sequence Library Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Nanobody Sequence Library Market Size (2020-2031)

7.2 Europe Nanobody Sequence Library Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Nanobody Sequence Library Market Size by Country (2020-2025)

7.4 Europe Nanobody Sequence Library Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Nanobody Sequence Library Market Size (2020-2031)

8.2 Asia-Pacific Nanobody Sequence Library Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Nanobody Sequence Library Market Size by Region (2020-2025)

8.4 Asia-Pacific Nanobody Sequence Library Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Nanobody Sequence Library Market Size (2020-2031)

9.2 Latin America Nanobody Sequence Library Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Nanobody Sequence Library Market Size by Country (2020-2025)

9.4 Latin America Nanobody Sequence Library Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Nanobody Sequence Library Market Size (2020-2031)

10.2 Middle East & Africa Nanobody Sequence Library Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Nanobody Sequence Library Market Size by Country (2020-2025)

10.4 Middle East & Africa Nanobody Sequence Library Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 GenScript ProBio

11.1.1 GenScript ProBio Company Details

11.1.2 GenScript ProBio Business Overview

11.1.3 GenScript ProBio Nanobody Sequence Library Introduction

11.1.4 GenScript ProBio Revenue in Nanobody Sequence Library Business (2020-2025)

11.1.5 GenScript ProBio Recent Development

11.2 Abiocenter

11.2.1 Abiocenter Company Details

11.2.2 Abiocenter Business Overview

11.2.3 Abiocenter Nanobody Sequence Library Introduction

11.2.4 Abiocenter Revenue in Nanobody Sequence Library Business (2020-2025)

11.2.5 Abiocenter Recent Development

11.3 Abace Biotechnology

11.3.1 Abace Biotechnology Company Details

11.3.2 Abace Biotechnology Business Overview

11.3.3 Abace Biotechnology Nanobody Sequence Library Introduction

11.3.4 Abace Biotechnology Revenue in Nanobody Sequence Library Business (2020-2025)

11.3.5 Abace Biotechnology Recent Development

11.4 KMDTM Bioscience

11.4.1 KMDTM Bioscience Company Details

11.4.2 KMDTM Bioscience Business Overview

11.4.3 KMDTM Bioscience Nanobody Sequence Library Introduction

11.4.4 KMDTM Bioscience Revenue in Nanobody Sequence Library Business (2020-2025)

11.4.5 KMDTM Bioscience Recent Development

11.5 Sino Biologics

11.5.1 Sino Biologics Company Details

11.5.2 Sino Biologics Business Overview

11.5.3 Sino Biologics Nanobody Sequence Library Introduction

11.5.4 Sino Biologics Revenue in Nanobody Sequence Library Business (2020-2025)

11.5.5 Sino Biologics Recent Development

11.6 WuXi Biologics

11.6.1 WuXi Biologics Company Details

11.6.2 WuXi Biologics Business Overview

11.6.3 WuXi Biologics Nanobody Sequence Library Introduction

11.6.4 WuXi Biologics Revenue in Nanobody Sequence Library Business (2020-2025)

11.6.5 WuXi Biologics Recent Development

11.7 Creative Biolabs

11.7.1 Creative Biolabs Company Details

11.7.2 Creative Biolabs Business Overview

11.7.3 Creative Biolabs Nanobody Sequence Library Introduction

11.7.4 Creative Biolabs Revenue in Nanobody Sequence Library Business (2020-2025)

11.7.5 Creative Biolabs Recent Development

11.8 Twist Bioscience

11.8.1 Twist Bioscience Company Details

11.8.2 Twist Bioscience Business Overview

11.8.3 Twist Bioscience Nanobody Sequence Library Introduction

11.8.4 Twist Bioscience Revenue in Nanobody Sequence Library Business (2020-2025)

11.8.5 Twist Bioscience Recent Development

11.9 ProteoGenix

11.9.1 ProteoGenix Company Details

11.9.2 ProteoGenix Business Overview

11.9.3 ProteoGenix Nanobody Sequence Library Introduction

11.9.4 ProteoGenix Revenue in Nanobody Sequence Library Business (2020-2025)

11.9.5 ProteoGenix Recent Development

11.10 Fortis Life Sciences

11.10.1 Fortis Life Sciences Company Details

11.10.2 Fortis Life Sciences Business Overview

11.10.3 Fortis Life Sciences Nanobody Sequence Library Introduction

11.10.4 Fortis Life Sciences Revenue in Nanobody Sequence Library Business (2020-2025)

11.10.5 Fortis Life Sciences Recent Development

11.11 Synbio Technologies

11.11.1 Synbio Technologies Company Details

11.11.2 Synbio Technologies Business Overview

11.11.3 Synbio Technologies Nanobody Sequence Library Introduction

11.11.4 Synbio Technologies Revenue in Nanobody Sequence Library Business (2020-2025)

11.11.5 Synbio Technologies Recent Development

11.12 KMD Bioscience

11.12.1 KMD Bioscience Company Details

11.12.2 KMD Bioscience Business Overview

11.12.3 KMD Bioscience Nanobody Sequence Library Introduction

11.12.4 KMD Bioscience Revenue in Nanobody Sequence Library Business (2020-2025)

11.12.5 KMD Bioscience Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Nanobody Sequence Library Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Immune Library

Table 3. Key Players of Natural Library

Table 4. Key Players of Fully Synthetic Library

Table 5. Global Nanobody Sequence Library Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Nanobody Sequence Library Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Nanobody Sequence Library Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Nanobody Sequence Library Market Share by Region (2020-2025)

Table 9. Global Nanobody Sequence Library Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Nanobody Sequence Library Market Share by Region (2026-2031)

Table 11. Nanobody Sequence Library Market Trends

Table 12. Nanobody Sequence Library Market Drivers

Table 13. Nanobody Sequence Library Market Challenges

Table 14. Nanobody Sequence Library Market Restraints

Table 15. Global Nanobody Sequence Library Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Nanobody Sequence Library Market Share by Players (2020-2025)

Table 17. Global Top Nanobody Sequence Library Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanobody Sequence Library as of 2024)

Table 18. Ranking of Global Top Nanobody Sequence Library Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Nanobody Sequence Library Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Nanobody Sequence Library, Headquarters and Area Served

Table 21. Global Key Players of Nanobody Sequence Library, Product and Application

Table 22. Global Key Players of Nanobody Sequence Library, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Nanobody Sequence Library Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Nanobody Sequence Library Revenue Market Share by Type (2020-2025)

Table 26. Global Nanobody Sequence Library Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Nanobody Sequence Library Revenue Market Share by Type (2026-2031)

Table 28. Global Nanobody Sequence Library Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Nanobody Sequence Library Revenue Market Share by Application (2020-2025)

Table 30. Global Nanobody Sequence Library Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Nanobody Sequence Library Revenue Market Share by Application (2026-2031)

Table 32. North America Nanobody Sequence Library Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Nanobody Sequence Library Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Nanobody Sequence Library Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Nanobody Sequence Library Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Nanobody Sequence Library Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Nanobody Sequence Library Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Nanobody Sequence Library Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Nanobody Sequence Library Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Nanobody Sequence Library Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Nanobody Sequence Library Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Nanobody Sequence Library Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Nanobody Sequence Library Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Nanobody Sequence Library Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Nanobody Sequence Library Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Nanobody Sequence Library Market Size by Country (2026-2031) & (US$ Million)

Table 47. GenScript ProBio Company Details

Table 48. GenScript ProBio Business Overview

Table 49. GenScript ProBio Nanobody Sequence Library Product

Table 50. GenScript ProBio Revenue in Nanobody Sequence Library Business (2020-2025) & (US$ Million)

Table 51. GenScript ProBio Recent Development

Table 52. Abiocenter Company Details

Table 53. Abiocenter Business Overview

Table 54. Abiocenter Nanobody Sequence Library Product

Table 55. Abiocenter Revenue in Nanobody Sequence Library Business (2020-2025) & (US$ Million)

Table 56. Abiocenter Recent Development

Table 57. Abace Biotechnology Company Details

Table 58. Abace Biotechnology Business Overview

Table 59. Abace Biotechnology Nanobody Sequence Library Product

Table 60. Abace Biotechnology Revenue in Nanobody Sequence Library Business (2020-2025) & (US$ Million)

Table 61. Abace Biotechnology Recent Development

Table 62. KMDTM Bioscience Company Details

Table 63. KMDTM Bioscience Business Overview

Table 64. KMDTM Bioscience Nanobody Sequence Library Product

Table 65. KMDTM Bioscience Revenue in Nanobody Sequence Library Business (2020-2025) & (US$ Million)

Table 66. KMDTM Bioscience Recent Development

Table 67. Sino Biologics Company Details

Table 68. Sino Biologics Business Overview

Table 69. Sino Biologics Nanobody Sequence Library Product

Table 70. Sino Biologics Revenue in Nanobody Sequence Library Business (2020-2025) & (US$ Million)

Table 71. Sino Biologics Recent Development

Table 72. WuXi Biologics Company Details

Table 73. WuXi Biologics Business Overview

Table 74. WuXi Biologics Nanobody Sequence Library Product

Table 75. WuXi Biologics Revenue in Nanobody Sequence Library Business (2020-2025) & (US$ Million)

Table 76. WuXi Biologics Recent Development

Table 77. Creative Biolabs Company Details

Table 78. Creative Biolabs Business Overview

Table 79. Creative Biolabs Nanobody Sequence Library Product

Table 80. Creative Biolabs Revenue in Nanobody Sequence Library Business (2020-2025) & (US$ Million)

Table 81. Creative Biolabs Recent Development

Table 82. Twist Bioscience Company Details

Table 83. Twist Bioscience Business Overview

Table 84. Twist Bioscience Nanobody Sequence Library Product

Table 85. Twist Bioscience Revenue in Nanobody Sequence Library Business (2020-2025) & (US$ Million)

Table 86. Twist Bioscience Recent Development

Table 87. ProteoGenix Company Details

Table 88. ProteoGenix Business Overview

Table 89. ProteoGenix Nanobody Sequence Library Product

Table 90. ProteoGenix Revenue in Nanobody Sequence Library Business (2020-2025) & (US$ Million)

Table 91. ProteoGenix Recent Development

Table 92. Fortis Life Sciences Company Details

Table 93. Fortis Life Sciences Business Overview

Table 94. Fortis Life Sciences Nanobody Sequence Library Product

Table 95. Fortis Life Sciences Revenue in Nanobody Sequence Library Business (2020-2025) & (US$ Million)

Table 96. Fortis Life Sciences Recent Development

Table 97. Synbio Technologies Company Details

Table 98. Synbio Technologies Business Overview

Table 99. Synbio Technologies Nanobody Sequence Library Product

Table 100. Synbio Technologies Revenue in Nanobody Sequence Library Business (2020-2025) & (US$ Million)

Table 101. Synbio Technologies Recent Development

Table 102. KMD Bioscience Company Details

Table 103. KMD Bioscience Business Overview

Table 104. KMD Bioscience Nanobody Sequence Library Product

Table 105. KMD Bioscience Revenue in Nanobody Sequence Library Business (2020-2025) & (US$ Million)

Table 106. KMD Bioscience Recent Development

Table 107. Research Programs/Design for This Report

Table 108. Key Data Information from Secondary Sources

Table 109. Key Data Information from Primary Sources

Table 110. Authors List of This Report

List of Figures

Figure 1. Nanobody Sequence Library Picture

Figure 2. Global Nanobody Sequence Library Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Nanobody Sequence Library Market Share by Type: 2024 VS 2031

Figure 4. Immune Library Features

Figure 5. Natural Library Features

Figure 6. Fully Synthetic Library Features

Figure 7. Global Nanobody Sequence Library Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Nanobody Sequence Library Market Share by Application: 2024 VS 2031

Figure 9. Drug Development Case Studies

Figure 10. Vaccine Research Case Studies

Figure 11. Biosensors Case Studies

Figure 12. Tumor Treatment Case Studies

Figure 13. Diagnostic Tools Case Studies

Figure 14. Nanobody Sequence Library Report Years Considered

Figure 15. Global Nanobody Sequence Library Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Nanobody Sequence Library Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Nanobody Sequence Library Market Share by Region: 2024 VS 2031

Figure 18. Global Nanobody Sequence Library Market Share by Players in 2024

Figure 19. Global Top Nanobody Sequence Library Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanobody Sequence Library as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Nanobody Sequence Library Revenue in 2024

Figure 21. North America Nanobody Sequence Library Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Nanobody Sequence Library Market Share by Country (2020-2031)

Figure 23. United States Nanobody Sequence Library Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Nanobody Sequence Library Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Nanobody Sequence Library Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Nanobody Sequence Library Market Share by Country (2020-2031)

Figure 27. Germany Nanobody Sequence Library Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Nanobody Sequence Library Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Nanobody Sequence Library Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Nanobody Sequence Library Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Nanobody Sequence Library Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Nanobody Sequence Library Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Nanobody Sequence Library Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Nanobody Sequence Library Market Share by Region (2020-2031)

Figure 35. China Nanobody Sequence Library Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Nanobody Sequence Library Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Nanobody Sequence Library Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Nanobody Sequence Library Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Nanobody Sequence Library Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Nanobody Sequence Library Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Nanobody Sequence Library Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Nanobody Sequence Library Market Share by Country (2020-2031)

Figure 43. Mexico Nanobody Sequence Library Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Nanobody Sequence Library Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Nanobody Sequence Library Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Nanobody Sequence Library Market Share by Country (2020-2031)

Figure 47. Turkey Nanobody Sequence Library Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Nanobody Sequence Library Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Nanobody Sequence Library Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. GenScript ProBio Revenue Growth Rate in Nanobody Sequence Library Business (2020-2025)

Figure 51. Abiocenter Revenue Growth Rate in Nanobody Sequence Library Business (2020-2025)

Figure 52. Abace Biotechnology Revenue Growth Rate in Nanobody Sequence Library Business (2020-2025)

Figure 53. KMDTM Bioscience Revenue Growth Rate in Nanobody Sequence Library Business (2020-2025)

Figure 54. Sino Biologics Revenue Growth Rate in Nanobody Sequence Library Business (2020-2025)

Figure 55. WuXi Biologics Revenue Growth Rate in Nanobody Sequence Library Business (2020-2025)

Figure 56. Creative Biolabs Revenue Growth Rate in Nanobody Sequence Library Business (2020-2025)

Figure 57. Twist Bioscience Revenue Growth Rate in Nanobody Sequence Library Business (2020-2025)

Figure 58. ProteoGenix Revenue Growth Rate in Nanobody Sequence Library Business (2020-2025)

Figure 59. Fortis Life Sciences Revenue Growth Rate in Nanobody Sequence Library Business (2020-2025)

Figure 60. Synbio Technologies Revenue Growth Rate in Nanobody Sequence Library Business (2020-2025)

Figure 61. KMD Bioscience Revenue Growth Rate in Nanobody Sequence Library Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Nanobody Sequence Library market? zhanKai

The top companies in the global Nanobody Sequence Library market are GenScript ProBio、Abiocenter、Abace Biotechnology.

Related Reports

Global Nanobody Sequence Library Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Nanobody Sequence Library market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-26
Pages: 145
USD 4900.00
(Single User License)
Global Nanobody Sequence Library Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Nanobody Sequence Library market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 92
USD 4250.00
(Single User License)
Nanobody Sequence Library - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Nanobody Sequence Library was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 103
USD 3950.00
(Single User License)
Global Nanobody Sequence Library Market Research Report 2026
The global Nanobody Sequence Library market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-14
Pages: 119
USD 2900.00
(Single User License)
Global Nanobody Sequence Library Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Nanobody Sequence Library market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 99
USD 4250.00
(Single User License)
Global Nanobody Sequence Library Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Nanobody Sequence Library market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-05
Pages: 136
USD 4900.00
(Single User License)
Nanobody Sequence Library - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Nanobody Sequence Library was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-11
Pages: 110
USD 3950.00
(Single User License)
Global Nanobody Sequence Library Market Research Report 2024
Nanobody (Nb) is an artificially designed antibody molecule, also known as single-domain antibodies (sdAbs), VHH antibodies or camelid antibodies. It is a kind of heavy-chain antibodies (HCAbs) that naturally lack light chains and are found in camelids such as alpacas and dromedaries, as well as cartilaginous fish such as sharks and rays. There are monovalent nanobodies, bivalent nanobodies, bispecific nanobodies, multivalent nanobodies and fused nanobodies.
Published Date: 2024-06-15
Pages: 83
USD 2900.00
(Single User License)
Global and United States Nanobody Sequence Library Market Report & Forecast 2024-2030
Nanobody (Nb) is an artificially designed antibody molecule, also known as single-domain antibodies (sdAbs), VHH antibodies or camelid antibodies. It is a kind of heavy-chain antibodies (HCAbs) that naturally lack light chains and are found in camelids such as alpacas and dromedaries, as well as cartilaginous fish such as sharks and rays. There are monovalent nanobodies, bivalent nanobodies, bispecific nanobodies, multivalent nanobodies and fused nanobodies.
Published Date: 2024-06-15
Pages: 114
USD 4350.00
(Single User License)
Global Nanobody Sequence Library Market Insights, Forecast to 2030
Nanobody (Nb) is an artificially designed antibody molecule, also known as single-domain antibodies (sdAbs), VHH antibodies or camelid antibodies. It is a kind of heavy-chain antibodies (HCAbs) that naturally lack light chains and are found in camelids such as alpacas and dromedaries, as well as cartilaginous fish such as sharks and rays. There are monovalent nanobodies, bivalent nanobodies, bispecific nanobodies, multivalent nanobodies and fused nanobodies.
Published Date: 2024-06-15
Pages: 138
USD 4900.00
(Single User License)

Global Nanobody Sequence Library Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Nanobody Sequence Library market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-26
Pages: 145
USD 4900.00 (Single User License)
Global Nanobody Sequence Library Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Nanobody Sequence Library market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 92
USD 4250.00 (Single User License)
Nanobody Sequence Library - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Nanobody Sequence Library was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 103
USD 3950.00 (Single User License)
Global Nanobody Sequence Library Market Research Report 2026
The global Nanobody Sequence Library market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-14
Pages: 119
USD 2900.00 (Single User License)
Global Nanobody Sequence Library Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Nanobody Sequence Library market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 99
USD 4250.00 (Single User License)
Global Nanobody Sequence Library Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Nanobody Sequence Library market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 136
USD 4900.00 (Single User License)
Nanobody Sequence Library - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Nanobody Sequence Library was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-11
Pages: 110
USD 3950.00 (Single User License)
Global Nanobody Sequence Library Market Research Report 2024
Nanobody (Nb) is an artificially designed antibody molecule, also known as single-domain antibodies (sdAbs), VHH antibodies or camelid antibodies. It is a kind of heavy-chain antibodies (HCAbs) that naturally lack light chains and are found in camelids such as alpacas and dromedaries, as well as cartilaginous fish such as sharks and rays. There are monovalent nanobodies, bivalent nanobodies, bispecific nanobodies, multivalent nanobodies and fused nanobodies.
Published: 2024-06-15
Pages: 83
USD 2900.00 (Single User License)
Global and United States Nanobody Sequence Library Market Report & Forecast 2024-2030
Nanobody (Nb) is an artificially designed antibody molecule, also known as single-domain antibodies (sdAbs), VHH antibodies or camelid antibodies. It is a kind of heavy-chain antibodies (HCAbs) that naturally lack light chains and are found in camelids such as alpacas and dromedaries, as well as cartilaginous fish such as sharks and rays. There are monovalent nanobodies, bivalent nanobodies, bispecific nanobodies, multivalent nanobodies and fused nanobodies.
Published: 2024-06-15
Pages: 114
USD 4350.00 (Single User License)
Global Nanobody Sequence Library Market Insights, Forecast to 2030
Nanobody (Nb) is an artificially designed antibody molecule, also known as single-domain antibodies (sdAbs), VHH antibodies or camelid antibodies. It is a kind of heavy-chain antibodies (HCAbs) that naturally lack light chains and are found in camelids such as alpacas and dromedaries, as well as cartilaginous fish such as sharks and rays. There are monovalent nanobodies, bivalent nanobodies, bispecific nanobodies, multivalent nanobodies and fused nanobodies.
Published: 2024-06-15
Pages: 138
USD 4900.00 (Single User License)